<scp>TAFRO</scp> syndrome was effectively treated with an inexpensive novel scheme: A case report-Reference-Cited by-同舟云学术

TAFRO syndrome was effectively treated with an inexpensive novel scheme: A case report

Published:2023-02 Issue:2 Volume:11 Page:
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clinical Case Reports

Author:

Meng Shan¹^ORCID,Liu Hailing¹^ORCID,Zhang Wanggang¹,He Aili¹,Sun Honghong²,Zhang Ru³,Chen Xiaoli⁴,Chen Yinxia¹

Affiliation:

1. Department of Hematology The Second Affiliated Hospital of Xi'an Jiaotong University Xi'an China

2. Medical Imaging Department The Second Affiliated Hospital of Xi'an Jiaotong University Xi'an China

3. Department of Neurology The Second Affiliated Hospital of Xi'an Jiaotong University Xi'an China

4. Pathology Department The Second Affiliated Hospital of Xi'an Jiaotong University Xi'an China

Abstract

AbstractA man diagnosed as TAFRO syndrome was successfully responded to a novel immunosuppressive regimen containing methylprednisolone and mycophenolate mofetil. Blood cells firstly recovered, followed by the general situation and complete recover 1 month later, highlighting the danger of TAFRO syndrome and the importance of immunosuppressive agents in reversing pathological course.

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.6183

Reference16 articles.

1. Case records of the Massachusetts General Hospital; weekly clinicopathological exercises; founded by Richard C;Castleman B;Cabot N Engl J Med,1954

2. Castleman Disease

3. Severe Complications from an Unexpectedly High Serum Mycophenolic Acid Concentration in a Patient with Renal Failure Secondary to Lupus Nephritis: A Case Report

4. Interleukin-6: designing specific therapeutics for a complex cytokine

5. A Phase I, Open-Label Study of Siltuximab, an Anti–IL-6 Monoclonal Antibody, in Patients with B-cell Non-Hodgkin Lymphoma, Multiple Myeloma, or Castleman Disease